| Entry |
|
| Name |
Norethindrone acetate (USP); Norethisterone acetate (JAN); Aygestin (TN) |
| Product |
|
| Generic |
NORETHINDRONE ACETATE (Amneal Pharmaceuticals LLC), NORETHINDRONE ACETATE (AvKARE), NORETHINDRONE ACETATE (Glenmark Pharmaceuticals), NORETHINDRONE ACETATE (Ingenus Pharmaceuticals), NORETHINDRONE ACETATE (Mylan Pharmaceuticals), NORETHINDRONE ACETATE (Rising Pharmaceuticals), NORETHINDRONE ACETATE (Teva Pharmaceuticals USA), AYGESTIN (Teva Women's Health) |
| Formula |
C22H28O3
|
| Exact mass |
340.2038
|
| Mol weight |
340.4559
|
| Structure |

|
| Simcomp |
|
| Class |
Hormonal agent
DG02004 Progesterone
DG01666 Progesterone receptor agonist
|
| Remark |
| ATC code: | G03AC01 G03DC02 |
| Chemical structure group: | DG00456 |
| Product (DG00456): | D00182<JP/US> D00953<US> |
| Product (mixture): | D04483<JP/US> D09188<JP/US> D12137<US> D12226<US> |
|
| Efficacy |
Contraceptive, Progesterone receptor agonist |
| Comment |
Progestin
|
| Target |
NR3C3 (PGR) [HSA:5241] [KO:K08556] |
| Pathway |
| hsa04914 | Progesterone-mediated oocyte maturation |
| hsa04915 | Estrogen signaling pathway |
|
| Interaction |
|
| Structure map |
| map07226 | Progesterone, androgen and estrogen receptor agonists/antagonists |
|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
G GENITO URINARY SYSTEM AND SEX HORMONES
G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
G03A HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE
G03AC Progestogens
G03AC01 Norethisterone
D00953 Norethindrone acetate (USP) <US>
G03D PROGESTOGENS
G03DC Estren derivatives
G03DC02 Norethisterone
D00953 Norethindrone acetate (USP) <US>
USP drug classification [BR:br08302]
Contraceptives
Oral Progestins
Norethindrone
D00953 Norethindrone acetate (USP)
Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)
Progestins
Norethindrone
D00953 Norethindrone acetate (USP)
Drug groups [BR:br08330]
Hormonal agent
DG02004 Progesterone
DG00456 Norethisterone
D00953 Norethindrone acetate
DG01666 Progesterone receptor agonist
DG00456 Norethisterone
D00953 Norethindrone acetate
Drug classes [BR:br08332]
Endocrine and hormonal agent
DG02004 Progesterone
D00953 Norethindrone acetate
Target-based classification of drugs [BR:br08310]
Nuclear receptors
Estrogen like receptors
3-Ketosteroid receptor
NR3C3 (PGR)
D00953 Norethindrone acetate (USP) <US>
Drug groups [BR:br08330]
Hormonal agent
DG02004 Progesterone
DG00456 Norethisterone
DG01666 Progesterone receptor agonist
DG00456 Norethisterone
|
| Other DBs |
|
| KCF data |
ATOM 25
1 C1z C 26.8820 -17.0674
2 C1z C 28.0682 -16.3895
3 C1y C 26.8705 -18.4405
4 C1x C 25.7075 -16.3836
5 C1a C 26.8762 -15.7000
6 C1x C 29.2545 -17.0791
7 O7a O 28.0567 -15.0162
8 C3b C 29.2487 -15.7000
9 C1y C 25.6842 -19.1184
10 C1x C 29.2429 -18.3822
11 C1x C 24.5155 -17.0557
12 C7a C 28.0567 -13.6548
13 C3a C 30.4292 -15.0105
14 C1y C 24.5038 -18.4231
15 C1x C 25.6842 -20.4917
16 C1a C 29.2429 -12.9710
17 O6a O 26.8762 -12.9769
18 C1y C 23.3175 -19.1009
19 C1x C 24.4921 -21.1696
20 C2y C 23.3118 -20.4800
21 C1x C 22.1371 -18.4172
22 C2x C 22.1371 -21.1636
23 C1x C 20.9508 -19.1009
24 C5x C 20.9508 -20.4800
25 O5x O 19.7588 -21.1579
BOND 28
1 1 2 1
2 1 3 1
3 1 4 1
4 1 5 1 #Up
5 2 6 1
6 2 7 1 #Up
7 2 8 1 #Down
8 3 9 1
9 3 10 1
10 4 11 1
11 7 12 1
12 8 13 3
13 9 14 1
14 9 15 1
15 12 16 1
16 12 17 2
17 14 18 1
18 15 19 1
19 18 20 1
20 18 21 1
21 20 22 2
22 21 23 1
23 22 24 1
24 24 25 2
25 6 10 1
26 11 14 1
27 19 20 1
28 23 24 1
|